Nonenzymatic isomerization of 9-cis-retinoic acid catalyzed by sulfhydryl compounds

Drug Metabolism and Disposition

Volumn 25, Issue 1, 1997, Pages 27-32

  Shih, Tzu Wen ^b   Lin, Tsu Han ^b   Shealy, Y Fulmer ^b   Hill, Donald L ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALITRETINOIN; GLUTATHIONE; ISOTRETINOIN; MECYSTEINE; MERCAPTOETHANOL; RETINOIC ACID;

ARTICLE; CONFORMATIONAL TRANSITION; DRUG CONFORMATION; DRUG DEGRADATION; DRUG PROTEIN BINDING; ISOMERISM; PRIORITY JOURNAL;

ANIMALS; CELL LINE; HUMANS; ISOTRETINOIN; MICE; MICROSOMES, LIVER; SULFHYDRYL COMPOUNDS; TRETINOIN;

EID: 0031013482     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. J. E. Dowling and G. Wald: The biological function of vitamin A acid. Proc. Natl. Acad. Sci. U.S.A. 46, 587-608 (1960).
2. A. B. Roberts and M. B. Sporn: Cellular biology and biochemistry of the retinoids. In "The Retinoids" (M. B. Sporn, A. B. Roberts, and D. S. Goodman, eds.), vol. 2, pp. 209-286. Academic Press, Orlando, 1984.
3. D. L. Hill and C. J. Grubbs: Retinoids and cancer prevention. Ann. Rev. Nutr. 12, 161-181 (1992).
4. B. P. Sani and R. G. Meeks: Subacute toxicity of all-trans- and 13-cis-isomers of N-ethyl retinamide, N-2-hydroxyethyl retinamide, and N-4-hydroxyphenyl retinamide. Toxicol. Appl. Pharmacol. 70, 228-235 (1983).
5. C. Lindamood III, D. L. Dillehay, E. W. Lamon, H. D. Giles, Y. F. Shealy, B. P. Sani, and D. L. Hill: Toxicologic and immunologic evaluations of N-(all-trans-retinoyl)-DL-leucine and N-(all-rrans-retinoyl)glycine. Toxicol. Appl. Pharmacol. 96, 279-295 (1988).
6. C. C. Willhite, M. I. Dawson, and K. J. Williams: Structure-activity relationships of retinoids in developmental toxicology. I. Studies on the nature of the polar terminus of the vitamin A molecule. Toxicol. Appl. Pharmacol. 74, 397-410 (1984).
7. C. C. Willhite and Y. F. Shealy: Amelioration of embryotoxicity by structural modification of the terminal group of cancer chemopreventive retinoids. J. Natl. Cancer Inst. 72, 689-695 (1984).
8. R. P. Warrell, Jr., S. R. Frankel, W. H. Miller, Jr., D. A. Scheinberg, L. M. Itri, W. N. Hittelman, R. Vyas, M. Andreeff, A. Tafuri, A. Jakubowski, J. Gabrilove, M. S. Gordon, and E. Dmitrovsky: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med. 324, 1385-1393 (1991).
9. J. P. Evard and W. Bollag: Konservative Behandlund der rezidivierenden Harnblasenpapillomatose mit Vitamin-A-Säure. Schweiz. Med. Wochenschr. 102, 1880-1883 (1972).
10. W. K. Hong, J. Endicott, L. M. Itri, W. Doos, J. G. Batsakis, R. Bell, S. Fofonoff, R. Byers, E. N. Atkinson, C. Vaughn, B. B. Toth, A. Kramer, I.W. Dimery, P. Skipper, and S. Strong: 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 315, 1501-1505 (1986).
11. W. K. Hong, S. M. Lippman, L. M. Itri, D.D. Karp, J. S. Lee, R. M. Byers, S. P. Schantz, A. M. Kramer, R. Lotan, L. J. Peters, I. W. Dimery, B. W. Brown, and H. Goepfert: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323, 795-801 (1990).
12. M. Petkovitch, N. J. Brand, A. Krust, and P. Chambon: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330, 444-450 (1987).
13. V. Giguere, E. S. Ong, P. Segui, and R. M. Evans: Identification of a receptor for the morphogen retinoic acid. Nature 330, 624-629 (1987).
14. M. Leid, P. Kastner, R. Lyons, H. Nakshatri, M. Saunders, T. Zacharewski, J. Y. Chen, A. Staub, J. M. Garnier, S. Mader, and P. Chambon: Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68, 377-395 (1992).
15. D. J. Mangelsdorf, K. Umesono, S. A. Kliewer, U. Borgmeyer, E. S. Ong, and R. M. Evans: A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66, 555-561 (1991).
16. R. A. Heyman, D. J. Mangelsdorf, J. A. Dyck, R. B. Stein, G. Eichele, R. M. Evans, and C. Thaller: 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68, 397-406 (1992).
17. A. A. Levin, L. J. Sturzenbecker, S. Kazmer, T. Bosakowski, C. Huselton, G. Allenby, J. Speck, C. Kratzeisen, M. Rosenberger, A. Lovey, and J. F. Grippo: 9-cis Retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355, 359-361 (1992).
18. X. K. Zhang, J. Lehmann, B. Hoffmann, M.I. Dawson, J. Cameron, G. Graupner, T. Hermann, P. Tran, and M. Pfahl: Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 358, 587-591 (1992).
19. J. R. Kalin, M. E. Starling, and D. L. Hill: Disposition of all-trans-retinoic acid in mice following oral doses. Drug Metab. Dispos. 9, 196-201 (1981).
20. M. H. Zile, R. J. Emerick, and H. F. DeLuca: Identification of 13-cis-retinoic acid in tissue extracts and its biological activity in rats. Biochim. Biophys. Acta 141, 639-641 (1967).
21. J. R. Kalin, M. J. Wells, and D. L. Hill: Disposition of 13-cis-retinoic acid and N-(2-hydroxyethyl)retinamide in mice following oral doses. Drug Metab. Dispos. 10, 391-398 (1982).
22. C. V. Puglisi and J. A. F. DeSilva: Determination of retinoic acid (13-cis- and all-trans) and aromatic retinoic acid analogs possessing antitumor activity, in biological fluids by high-performance liquid chromatography. J. Chromatogr. 152, 421-430 (1978).
23. F. M. Vane, C. J. L. Buggé, and T. H. Williams: Metabolism of 13-cis-retinoic acid by a rat liver 9000g supernatant preparation. Drug Metab. Dispos. 10, 212-219 (1982).
24. A.M. McCormick, K. D. Kroll, and J. L. Napoli: 13-cis-Retinoic acid metabolism in vivo. The major tissue metabolites in the rat have all-trans configuration. Biochemistry 22, 3933-3940 (1983).
25. M. H. Zile, R. C. Inhorn, and H. F. DeLuca: Metabolism in vivo of all-trans-retinoic acid. Biosynthesis of 13-cis-retinoic acid and all-trans- and 13-cis-retinoyl glucuronides in the intestinal mucosa of the rat. J. Biol. Chem. 257, 3544-3550 (1982).
26. M. H. Zile, R. C. Inhorn, and H. F. DeLuca: Metabolites of all-trans-retinoic acid in bile: identification of all-trans- and 13-cis-retinoyl glucuronides. J. Biol. Chem. 257, 3537-3542 (1982).
27. C. A. Frolik, P. P. Roller, A. B. Roberts, and M. B. Sporn: In vitro and in vivo metabolism of all-trans- and 13-cis-retinoic acid in hamsters. Identification of 13-cis-4-oxoretinoic acid. J. Biol. Chem. 255, 8057-8062 (1980).
28. P. A. Lehman and A. M. Malany: Evidence for percutaneous absorption of isotretinoin from the photo-isomerization of topical tretinoin. J. Invest. Dermatol. 93, 595-599 (1989).
29. T. W. Shih, Y. F. Shealy, D. L. Strother, and D. L. Hill: Nonenzymatic isomerization of all-trans and 13-cis-retinoids catalyzed by sulfhydryl groups. Drug Metab. Dispos. 14, 698-702 (1986).
30. J. O. Sass, A. Forster, K. W. Bock, and H. Nau: Glucuronidation and isomerization of all-trans- and 13-cis-retinoic acid by liver microsomes of phenobarbital-or 3-methylcholanthrene-treated rats. Biochem. Pharmacol. 47, 485-492 (1994).
31. R. C. Jewell and P. J. McNamara: Glutathione catalysis of interconversion of acitretin and its 13-cis isomer isoacitretin. J. Pharmaceut. Sci. 79, 444-446 (1990).
32. J. Urbach and R. R. Rando: Isomerization of all-trans-retinoic acid to 9-cis-retinoic acid. Biochem. J. 299, 459-465 (1994).
33. R. Kojima, T. Fujimori, N. Kiyota, Y. Toriya, T. Fukuda, T. Ohashi, T. Sato, Y. Yoshizawa, K. Takeyama, H. Mano, S. Masushige, and S. Kato: In vivo isomerization of retinoic acids: rapid isomer exchange and gene expression. J. Biol. Chem. 269, 32700-32707 (1994).
34. G. Tzimas, J. O. Sass, W. Wittfoht, M. M. A. Elmazar, K. Ehler, and H. Nau: Identification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos. Drug Metab. Dispos. 22, 928-936 (1994).
35. R. L. Horst, T. A. Reinhardt, J. P. Goff, N. J. Koszewski, and J. L. Napoli: 9,13-Di-cis-retinoic acid is the major circulating geometric isomer of retinoic acid in the periparturient period. Arch. Biochem. Biophys. 322, 235-239 (1995).
36. J. M. Kurie, J. Buck, T. M. Eppinger, D. Moy, and E. Dmitrovsky: 9-Cis and all-trans retinoic acid induce a similar phenotype in human teratocarcinoma cells. Differentiation 54, 123-129 (1993).
37. A. Murayama, T. Suzuki, and M. Matsui: Biological effect of 9-cis-retinoic acid and 9,13-di-cis-retinoic acid on human acute promyelocytic leukemia cell line HL-60. Proc. Jpn. Acad. Ser. B 69, 185-190 (1993).
38. C.-C. Wang and D. L. Hill: Retinoid acid esterase activities: tissue and subcellular distribution in mice. Biochem. Pharmacol. 26, 947-950 (1977).
39. M. M. Bradford: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976).
40. G. W. Robinson, R. A. Bradshaw, L. Kanarek, and R. L. Hill: The thiol groups of fumarase. J. Biol. Chem. 242, 2709-2718 (1967).
41. G. G. Kelley, M. H. Vail, D. J. Adamson, and E. A. Palmer: The isolation and propagation of human epidermoid carcinoma cells resistant to 6-mercaptopurine. Am. J. Hygiene 73, 231-235 (1961).
42. i cotransporter. Am. J. Physiol. 260, F874-882.
43. S. Seltzer: cis-trans-Isomerization. In "The Enzymes" (P. Boyer, ed.), vol. 6, pp. 381-406. Academic Press, New York, 1972.
44. S. Seltzer and M. Lin: Maleylacetone cis-trans-isomerase. Mechanism of interaction of coenzyme glutathione and substrate maleylacetone in the presence and absence of enzyme. J. Am. Chem. Soc. 101, 3091-3097 (1979).
45. K. Nozaki and R. Ogg, Jr.: cis-trans-Isomerization. I. The mechanism of a catalyzed isomerization of maleic acid to fumaric acid. J. Am. Chem. Soc. 63, 2583-2586 (1941).
46. K. D. Stevens and S. Seltzer: Thiocyanate-catalyzed cis-trans-isomerization of cis-beta-acetylacrylic acid. A model for maleylacetoacetic acid. J. Org. Chem. 33, 3922-3928 (1968).
47. W. G. Niehaus, Jr.: Thiol-catalyzed cis-trans isomerization of oleic acid. Bioorg. Chem. 3, 302-310 (1974).
48. N. Noy: The ionization behavior of retinoic acid in aqueous environments and bound to serum albumin. Biochim. Biophys. Acta 1106, 151-158 (1992).
49. R. M. Brito and W. L. C. Vaz: Determination of the critical micelle concentration of surfactants using the fluorescent probe N-phenyl-1-naphthylamine. Anal. Biochem. 152, 250-255 (1986).
50. R. Hamm and K. Hofmann: Changes in the sulphydryl and disulphide groups in beef muscle proteins during beef muscle proteins during heating. Nature 207, 1269-1271 (1965).
51. R. R. Crichton: Struktur and Funktion von Ferritin. Angew. Chem. 85, 53-62 (1973).
52. A. Svenson and J. Carlsson: The thiol group of bovine serum albumin. High reactivity at acidic pH as measured by the reaction with 2,2′-dipyridyl disulphide. Biochim. Biophys. Acta 400, 433-438 (1975).
53. M. J. Meredith and D. J. Reed: Status of the mitochondrial pool of glutathione in the isolated hepatocyte. J. Biol. Chem. 257, 3747-3753 (1982).
54. R. A. Kramer, K. Greene, S. Ahmad, and D. T. Vistica: Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine. Cancer Res. 47, 1593-1597 (1987).
55. H. Ohara and T. Terasima: Variations of cellular sulfhydryl content during cell cycle of HeLa cells and its correlation to cyclic change of X-ray sensitivity. Exp. Cell Res. 58, 182-185 (1969).